A study in lung cancer has shown tumour cells that express CFH can prevent complement activation in vivo and protect tumour cells from complement‐mediated cytolysis, thereby promoting tumour development (Ajona, Hsu, Corrales, Montuenga, & Pio, 2007). This evidence concerns the gene CFH and lung cancer.